HIV clinical trials in Nevada
4 studies for HIV are looking for participants at sites in Nevada.
Cities in Nevada
A Study to Investigate Cabotegravir Ultra Long-Acting (CAB ULA) Plus Rilpivirine Ultra Long-Acting (RPV ULA) in Adults and Adolescents With HIV Who Are Virologically Suppressed
- GSK Investigational Site, Las Vegas
RecruitingPhase 3
Ages 12 and older · All sexes · Updated Sep 28, 2026 · NCT07650916REINItiation of Antiretroviral Therapy Using Oral bicTegravir, emtrIcitAbine and Tenofovir alafenamidE
- CAN Community Health, Las Vegas
RecruitingPhase 4
Ages 18 and older · All sexes · Updated Sep 3, 2026 · NCT07476339A Study to Investigate Pharmacokinetics, Safety and Tolerability of Long-Acting Cabotegravir Plus Recombinant Human Hyaluronidase PH20 in Healthy Adult Participants
- GSK Investigational Site, Las Vegas
RecruitingPhase 1Healthy volunteers welcome
Ages 18 to 55 · All sexes · Updated Dec 18, 2025 · NCT05418868A Study to Assess the Safety, Tolerability, and Pharmacokinetics of VH4011499 Compared to Placebo in Adults Without HIV
- GSK Investigational Site, Las Vegas
RecruitingPhase 1Healthy volunteers welcome
Ages 18 to 55 · All sexes · Updated Oct 29, 2025 · NCT06724640From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.